Gabriel Billings has a long history of work experience in Computational Biology. Gabriel began their career in 2009 as a Graduate Student at Stanford University. In 2015, they moved on to Harvard Medical School as a Postdoctoral Research Fellow. In 2019, they joined Kintai Therapeutics as a Scientist, Computational Biology and was promoted to Senior Scientist, Computational Biology. Currently, they work at ProFound Therapeutics as an Associate Director, Computational Biology.
Gabriel Billings received their Doctor of Philosophy (Ph.D.) in Physics from Stanford University in 2015. Prior to that, they obtained a BS in Physics from Yale University in 2008.
March 1, 2024 - present
August, 2021
July, 2020
Director, Computational Biology at AnimaBiotech
Director, Computational Biology at Immunitas Therapeutics
Director, Computational Biology at Engitix Therapeutics
Director, Computational Biology at Cabaletta Bio
Director, Computational Biology at TRex Bio